Of Mice and Men

[1]  Richard Coppola,et al.  Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine , 2009, Biological Psychiatry.

[2]  H. Engler,et al.  PET imaging of amyloid deposition in patients with mild cognitive impairment , 2008, Neurobiology of Aging.

[3]  M. Egan,et al.  Verbal and visual memory: Characterizing the clinical and intermediate phenotype in schizophrenia , 2008, Schizophrenia Research.

[4]  J. Lassalle,et al.  Effects of the genetic background on cognitive performances of TG2576 mice , 2008, Behavioural Brain Research.

[5]  W. Carpenter,et al.  The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities , 2008, Neuropsychopharmacology.

[6]  O. Sporns,et al.  Mapping the Structural Core of Human Cerebral Cortex , 2008, PLoS biology.

[7]  J. Shega,et al.  Integrating Palliative Medicine into the Care of Persons with Advanced Dementia: Identifying Appropriate Medication Use , 2008, Journal of the American Geriatrics Society.

[8]  Tom Michael Mitchell,et al.  Predicting Human Brain Activity Associated with the Meanings of Nouns , 2008, Science.

[9]  E. Schutter.  Why Are Computational Neuroscience and Systems Biology So Separate? , 2008, PLoS Comput. Biol..

[10]  A. Korczyn.  The amyloid cascade hypothesis , 2008, Alzheimer's & Dementia.

[11]  J. Varner,et al.  A Test of Highly Optimized Tolerance Reveals Fragile Cell-Cycle Mechanisms Are Molecular Targets in Clinical Cancer Trials , 2008, PloS one.

[12]  W. Roberts,et al.  Episodic-Like Memory in Rats: Is It Based on When or How Long Ago? , 2008, Science.

[13]  K. Yoshizato,et al.  Chimeric mice with humanized liver. , 2008, Toxicology.

[14]  Abraham Weizman,et al.  A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effects. , 2008, Journal of medicinal chemistry.

[15]  A. Fisher.  M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer’s Disease – The Pivotal Role of Brain M1 Receptors , 2008, Neurodegenerative Diseases.

[16]  P. Remy,et al.  Executive Functions Deficit in Mild Cognitive Impairment , 2007, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[17]  J. Waddington,et al.  Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice , 2007, Behavioural Brain Research.

[18]  Nicola Vanacore,et al.  Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised Trials , 2007, PLoS medicine.

[19]  Paul Maruff,et al.  β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease , 2007 .

[20]  W. Drinkenburg,et al.  Sleep and EEG profile in neonatal hippocampal lesion model of schizophrenia , 2007, Physiology & Behavior.

[21]  David E. Gloriam,et al.  The G protein-coupled receptor subset of the rat genome , 2007, BMC Genomics.

[22]  S. DeKosky,et al.  Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease. , 2007, Archives of neurology.

[23]  J. Callicott,et al.  Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. , 2007, Cerebral cortex.

[24]  A. Dagher,et al.  Conditioned Dopamine Release in Humans: A Positron Emission Tomography [11C]Raclopride Study with Amphetamine , 2007, The Journal of Neuroscience.

[25]  T. Stroup.  Heterogeneity of treatment effects in schizophrenia. , 2007, The American journal of medicine.

[26]  J. Costentin,et al.  Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission , 2007, British journal of pharmacology.

[27]  Thomas Dierks,et al.  A pharmaco-EEG study on antipsychotic drugs in healthy volunteers , 2007, Psychopharmacology.

[28]  Ransom K. Winder,et al.  Functional connectivity in fMRI: A modeling approach for estimation and for relating to local circuits , 2007, NeuroImage.

[29]  H. Geerts.  Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease. , 2007, IDrugs : the investigational drugs journal.

[30]  E. Bullmore,et al.  Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia. , 2007, Archives of general psychiatry.

[31]  B. Lamb,et al.  Genetic and environmental modifiers of Alzheimer's disease phenotypes in the mouse. , 2006, Current Alzheimer research.

[32]  K. Grill-Spector,et al.  High-resolution imaging reveals highly selective nonface clusters in the fusiform face area , 2006, Nature Neuroscience.

[33]  P Erdi,et al.  From systems biology to dynamical neuropharmacology: proposal for a new methodology. , 2006, Systems biology.

[34]  Zvia Agur,et al.  Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model. , 2006, Cancer research.

[35]  Jonathan D. Cohen,et al.  Imaging valuation models in human choice. , 2006, Annual review of neuroscience.

[36]  Marc W Kirschner,et al.  The Meaning of Systems Biology , 2005, Cell.

[37]  G. Meno-Tetang,et al.  On the prediction of the human response: a recycled mechanistic pharmacokinetic/pharmacodynamic approach. , 2005, Basic & clinical pharmacology & toxicology.

[38]  J. Callicott,et al.  Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. , 2004, The American journal of psychiatry.

[39]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[40]  R. Sullivan,et al.  Hemispheric Asymmetry in Stress Processing in Rat Prefrontal Cortex and the Role of Mesocortical Dopamine , 2004, Stress.

[41]  Y. Smith,et al.  Distribution of mGluR1α and mGluR5 immunolabeling in primate prefrontal cortex , 2003 .

[42]  G. W. Price,et al.  Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. , 2003, Molecular pharmacology.

[43]  S. Kapur,et al.  Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[44]  I. Glick,et al.  A meta-analysis of the efficacy of second-generation antipsychotics , 2003, Schizophrenia Research.

[45]  Roland E. Suri,et al.  TD models of reward predictive responses in dopamine neurons , 2002, Neural Networks.

[46]  Robert V Farese,et al.  Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Donatella Marazziti,et al.  Distribution of [3H]GR65630 Binding in Human Brain Postmortem , 2001, Neurochemical Research.

[48]  J. Gorman,et al.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P. Tooney,et al.  Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex , 2000, Neuroscience Letters.

[50]  S. Kapur,et al.  Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. , 2000, The American journal of psychiatry.

[51]  Doyle,et al.  Highly optimized tolerance: robustness and design in complex systems , 2000, Physical review letters.

[52]  B. Moghaddam,et al.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. , 1998, Science.

[53]  M. Ebert,et al.  Characterization of Desamino-5-[125I]Iodo-3-Methoxy-Zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[54]  C. Whitty,et al.  Neurokinin receptor mRNA localization in human midbrain dopamine neurons , 1997, The Journal of comparative neurology.

[55]  J. Trojanowski,et al.  Rational design of an animal model for alzheimer's disease: introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent , 1996, Neurobiology of Aging.

[56]  A. R. Howard.  Further validation studies of the Wechsler Memory Scale. , 1954, Journal of clinical psychology.

[57]  A. Hodgkin,et al.  A quantitative description of membrane current and its application to conduction and excitation in nerve , 1952, The Journal of physiology.

[58]  Chad B. Sandusky,et al.  Animal Models in Spinal Cord Injury: A Review , 2008, Reviews in the neurosciences.

[59]  Shesharao M. Wanjerkhede,et al.  Modeling the sub-cellular signaling pathways involved in reinforcement learning at the striatum. , 2008, Progress in brain research.

[60]  M. Shahid,et al.  Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challenges. , 2008, Current opinion in investigational drugs.

[61]  S. H. Joo,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[62]  Alex Bangs,et al.  Predictive biosimulation and virtual patients in pharmaceutical R and D. , 2005, Studies in health technology and informatics.

[63]  N. Kalkkinen,et al.  Molecular cloning and characterization of rat liver catechol-O-methyltransferase. , 1990, Gene.